Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingRegence Whole-Body CT Screening Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentRegence BlueCross BlueShieldPolicy 40

    Whole Body Computed Tomography (CT) Screening

    Customize your policy alerts

    Sign up for regence Policy 40 alerts

    Get alerted when Policy 40 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of whole-body CT scanning from the neck to the pelvis for screening asymptomatic individuals; excludes follow-up screening for individuals with a history of cancer.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyWhole Body Computed Tomography (CT) Screening
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJuly 1, 2027
    Key ActionTreat whole-body CT screening in asymptomatic individuals as investigational and subject to denial.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    InvestigationalCoverage status
    Neck to pelvisScreening range
    76497Procedure code
    No specific codeCoding limitation

    Coverage Criteria

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Asymptomatic Whole-Body CT Screening

    Coverage is considered investigational when whole-body CT is used to screen for disease in an asymptomatic individual.

    Asymptomatic whole-body CT screening: Whole-body computed tomography (CT) scanning is used as a screening tool for disease in an individual without symptoms.

    Investigational and not covered under this policy.

    This policy does not apply to follow-up screening in an individual with a history of cancer.

    Coding

    CPTCPT
    76497Unlisted computed tomography procedure (eg diagnostic, interventional)
    HCPCSHCPCS
    No codes listed

    Provider Actions

    Denial Risk

    Asymptomatic whole-body CT screening is subject to denial

    Do not expect coverage for whole-body CT scanning used as a screening tool for disease in an asymptomatic individual. This use is considered investigational and is subject to denial under the policy.

    Background

    Whole-body CT scanning images the body from the neck to the pelvis and has been proposed as a general screening test for diseases involving the thyroid, lungs, heart, and abdominal and pelvic organs. In asymptomatic individuals, current evidence does not demonstrate improved health outcomes and may lead to incidental findings, additional follow-up imaging, radiation exposure, and possible long-term cancer risk.

    Not Covered

    Whole-body CT screening in asymptomatic individuals is not covered because it is considered investigational. No evidence-based clinical practice guidelines or position statements recommend whole-body CT screening for disease in individuals without symptoms.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyWhole Body Computed Tomography (CT) Screening
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJuly 1, 2027
    Key ActionTreat whole-body CT screening in asymptomatic individuals as investigational and subject to denial.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider ActionsBackgroundNot Covered